- Home
- MDGL vs CAVA Comparison
MDGL vs CAVA Comparison
Compare MDGL & CAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MDGL | CAVA |
|---|---|---|
| Founded | 2011 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.0B | 8.1B |
| IPO Year | 2005 | 2023 |
Fundamental Metrics
Financial Performance| Metric | MDGL | CAVA |
|---|---|---|
| Price | $435.78 | $78.44 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 20 |
| Target Price | ★ $637.92 | $84.89 |
| AVG Volume (30 Days) | 351.2K | ★ 3.6M |
| Earning Date | 05-19-2026 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 41.32 | N/A |
| EPS | N/A | ★ 0.54 |
| Revenue | $180,133,000.00 | ★ $1,179,664,000.00 |
| Revenue This Year | $54.74 | $22.75 |
| Revenue Next Year | $45.72 | $20.23 |
| P/E Ratio | ★ N/A | $145.81 |
| Revenue Growth | N/A | ★ 22.41 |
| 52 Week Low | $265.00 | $43.41 |
| 52 Week High | $615.00 | $97.98 |
Technical Indicators
Market Signals| Indicator | MDGL | CAVA |
|---|---|---|
| Relative Strength Index (RSI) | 35.72 | 58.92 |
| Support Level | $410.78 | $62.15 |
| Resistance Level | $452.22 | $91.96 |
| Average True Range (ATR) | 19.50 | 3.90 |
| MACD | -0.81 | 1.13 |
| Stochastic Oscillator | 13.84 | 61.92 |
Price Performance
Historical ComparisonAbout MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
About CAVA CAVA Group Inc.
Cava Group Inc owns and operates a chain of restaurants. It is the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. The company's dips, spreads, and dressings are centrally produced and sold in grocery stores. The company's operations are conducted as two reportable segments: CAVA and Zoes Kitchen. The company generates all of its revenue from the CAVA segment.